EXPERIENCE OF TREATMENT WITH IBANDRONIC ACID IN PATIENTS WITH SEVERE RHEUMATOLOGICAL DISEASES AND SYSTEMIC OSTEOPOROSIS

This article presents the results of a study of effectiveness and safety of ibandronic acid in 21 children with rheumatologic diseases and severe systemic osteoporosis. The treatment with ibandronic acid during 48 weeks provided statistically significant increase of mineral density of bones, decreas...

Full description

Saved in:
Bibliographic Details
Published inVoprosy sovremennoĭ pediatrii Vol. 9; no. 1; pp. 116 - 121
Main Authors A.O. Lisitsyn, E.I. Alexeeva, V.G. Pinelis, M.I. Bakanov, S.I. Valieva, T.M. Bzarova
Format Journal Article
LanguageEnglish
Published "Paediatrician" Publishers LLC 01.01.2010
Online AccessGet full text

Cover

More Information
Summary:This article presents the results of a study of effectiveness and safety of ibandronic acid in 21 children with rheumatologic diseases and severe systemic osteoporosis. The treatment with ibandronic acid during 48 weeks provided statistically significant increase of mineral density of bones, decrease of pain intensity, lessening of serum concentration of bone resorption marker — C-terminal telopeptide. The development of repeated compressive fractures of vertebrae and bones of peripheral skeleton at the time of treatment with this medication was not detected. Key words: children, rheumatological diseases, osteoporosis, treatment, bifosfonates, ibandronic acid.(Voprosy sovremennoi pediatrii — Current Pediatrics. 2010;9(1):116-121)
ISSN:1682-5527
1682-5535